OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Publication Date
Release Date
2016
(7)
2017
(6)
2014
(6)
2019
(5)
2015
(5)
2018
(4)
2009
(4)
2021
(3)
2020
(3)
2008
(3)
2012
(2)
2011
(2)
2024
(1)
2023
(1)
2013
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048.
Not available
S-EPMC6400131
|
biostudies-literature
Cite
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Not available
S-EPMC3164246
|
biostudies-literature
Cite
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.
Not available
S-EPMC4872349
|
biostudies-literature
Cite
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome.
Not available
S-EPMC2733077
|
biostudies-literature
Cite
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
Not available
S-EPMC4066886
|
biostudies-literature
Cite
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Not available
S-EPMC8992729
|
biostudies-literature
Cite
RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
Not available
S-EPMC4773428
|
biostudies-literature
Cite
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Not available
S-EPMC6040651
|
biostudies-literature
Cite
Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.
Not available
S-EPMC4171844
|
biostudies-literature
Cite
Non-specific filtering of beta-distributed data.
Not available
S-EPMC4230495
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets